A recent study published by JAMA Psychiatry found a small increased risk for adolescents to develop type 2 diabetes as a result of using selective serotonin reuptake inhibitors (SSRI). SSRI’s such as Paxil, Zoloft, or Celexa are prescribed to treat depression and anxiety in patients. As more adolescents and young people are diagnosed with anxiety and depression disorders, SSRI use has grown as these patients initiate treatment.
The Study Findings
The study included a total of 1.5 million patients, approximately 500,000 of whom were treated with SSRI. The results showed that for those treated with SSRI’s, there was roughly a 13% increased risk of developing Type 2 Diabetes compared to those untreated. This result was primarily found in publicly insured patients, and less so in privately insured patients. For patients that were on continuous treatments using SSRI’s, this association was slightly higher. The risk was not apparent in the first year of treatment but grew with more years of continuous use of the antidepressants.
What Does this Mean for Me?
The JAMA study showed that the risk is lower than initially reported and primarily present with continuous treatment using SSRI’s. Prior to this study, the research done has primarily focused on the effect of SSRI’s on adults and their likelihood of developing Type 2 Diabetes. Overall, the researchers caution that the risk be considered against the effectiveness and benefits that the antidepressants offer for patients. While the association is low, it is important for patients to understand their risks and make informed treatment decisions.
Get in Touch with an Experienced Attorney for Help
If you believe that you or your child have developed Type 2 Diabetes as a result of prolonged treatment of SSRI’s, contact our caring and experienced attorneys. Calling as soon as you think you may have a case is important so you can investigate all of your options. Diabetes can be a lifetime diagnosis, get the assistance you deserve, call us today.
